Physician profile
Eric S Guerrant
NPI 1588693444
$1,142.02
in general payments reported to CMS, 2019-2025
17 companies · $256 in 2025
The $256 reported for 2025 was more than what 87% of Emergency Medicine providers received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $465 · 2020: $64.66 · 2021: $84.76 · 2022: $49.93 · 2023: $101 · 2024: $120 · 2025: $256.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $477.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $477.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $266.92 | 2019-2021 | |
| Ceribell, INC. | $156.72 | 2025 | Pocket Eeg Device |
| Portola Pharmaceuticals, LLC | $136.55 | 2019 | |
| Csl Behring | $106.02 | 2024-2025 | Kcentra |
| Penumbra, INC. | $96.15 | 2024 | Indigo System |
| Livanova USA, INC. | $73.20 | 2023 | Lifesparc |
| Chiesi USA, INC. | $51.52 | 2021-2025 | Kengreal, Cleviprex |
| Astrazeneca Pharmaceuticals LP | $48.91 | 2019-2022 | |
| Allergan, INC. | $42.30 | 2019-2020 | |
| Abbvie INC. | $40.42 | 2021 | |
| Vifor Pharma, INC. | $30.51 | 2019 | |
| Janssen Pharmaceuticals, INC | $27.22 | 2019 | |
| Merck Sharp & Dohme LLC | $15.53 | 2019 | |
| Vyaire Medical, INC. | $13.80 | 2022 | |
| Biomerieux INC | $12.86 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $12.66 | 2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $10.73 | 2023 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Guerrant listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.